Drug · DIN 02248297
EVRA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 25, 2022; first marketed December 24, 2003.
- Drug Identification Number (DIN)
- 02248297
- Company (DIN owner)
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Patch (Extended-Release)
- Route
- Transdermal
- Therapeutic class (ATC)
- Norelgestromin and estrogen G03AA13
- Class
- Human
- Record last updated
- September 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NORELGESTROMIN | 200 MCG | 24 HOUR |
| ETHINYL ESTRADIOL | 35 MCG | 24 HOUR |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 29, 2022: NOC 28045New Drug Submission (NDS) · Administrative: Change in Product Ownership
- November 19, 2003: NOC 3365Supplement to a New Drug Submission (SNDS) · New manufacturing site for the drug product